Infection and sepsis remain major global health priorities and present specific challenges to intensive care practice. Building on ESICM’s education initiatives in infection management, sepsis, and antimicrobial stewardship (AMS), including LIVES workshops, fellowships, and digital learning modules, this programme delivers a hybrid model. It combines ESICM-led centralised activities (ensuring scientific quality and consistency) with decentralised, country-specific activities (supporting national adaptation and capacity building). AMS remains a cross-cutting priority aligned with EU and global health policy priorities.
Andrew CONWAY MORRIS MD, PhD, MRC – Clinician Scientist, University of Cambridge; Honorary Consultant in Intensive Care Medicine, Addenbrookes Hospital, Cambridge, United Kingdom
Liesbet DE BUS MD PhD, Department of Critical Care Medicine, Ghent University Hospital, Ghent; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
Claire ROGER MD PhD – Head of Surgical Intensive Care Unit Anesthesia, Intensive Care, Pain and Emergency Department University Hospital Carémeau Nimes, University Nimes, France.
A structured ESICM education pathway combining centralised learning with country-tailored activities, supporting intensive care professionals in infection management, sepsis, and antimicrobial stewardship (AMS).
✅ 24-month programme (2026–2027)
✅ Free access
✅ Open to participants worldwide (priority access for selected activities in pilot countries). Registration details will be published in January 2026.
Pathway timeline (2026–2027)
Key milestones across Levels 1–3 and faculty development activities.
What does the programme include?
Centralised activities (ESICM-led)
Decentralised activities (national hubs)
Pilot phase: National Training Hubs
The pilot phase will run in five European countries: Poland, Portugal, Romania, Sweden, and the United Kingdom.
Participants from these countries receive priority access to selected onsite events and fellowship opportunities.
A total of 15 Fellowships are offered in 2026. These opportunities are open to participants who have demonstrated sufficient attendance and assessment performance. Successful applicants will undertake fellowships in specific areas of the pathway, gaining bedside teaching from experts at globally renowned academic health sciences centres.
Centres and tutors: To be confirmed (TBC)
Eligibility and Application
Final Selection: Decisions will be made by the expert evaluators.
Membership: Applicants must be members of ESICM (join now if you are not already a member).
Attendance: Applicants must have completed all online components of Level 1 and Level 2.
Selection Criteria: Fellowships will be awarded based on:
Quality of the application
Performance in the post-course quiz
For applicants who have previously received a fellowship, evidence of how past fellowship outcomes were implemented or disseminated may be requested
Thanks to the unrestricted educational support from bioMérieux. The programme has not been influenced in any way by its sponsor.
Endorsement: The pathway is endorsed by the Infection Section, the Pharmacology and Pharmacotherapy Section, and the Systemic Inflammation and Sepsis Section, ESICM.
Further questions? Contact us at education@esicm.org
